Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: a multicentre retrospective study
-
Published:2024-01
Issue:
Volume:67
Page:102378
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Xiang Danhong,
Yang Xiudi,
Qian Honglan,
Zhang Li,
Han Yanxia,
Sun Yongcheng,
Lu YingORCID,
Chen Yu,
Cao Dan,
Hu Meiwei,
Wang Lifeng,
Tang Qinli,
Wu DijiongORCID,
Tian Guoyan,
Tong Hongyan,
Jin Jie,
Huang Jian
Reference25 articles.
1. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms;Vainchenker;Blood,2017
2. Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives;Baumeister;Cells,2021
3. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study;Tefferi;J Clin Oncol,2011
4. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases;Panteli;Br J Haematol,2005
5. 3023 mayo clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups;Szuber;Mayo Clin Proc,2019